A year for change

Article

2009 has started with a bang...

2009 has started with a bang. Less than two weeks into the New Year, a shock announcement came from global healthcare and medical device firm Abbott, as it publicized its acquisition of AMO. For Abbott, the acquisition will see the addition of a brand new business division to its extensive medical device portfolio, allowing it to gain a brand new customer base and to further diversify risk; undeniably a positive move, particularly in these uncertain economic conditions. The purchase will also catapult Abbott into a leading position within the global ophthalmic market, which is previously unchartered territory for the company. For AMO, Abbott offers strong financial support as well as a new perspective for growth and expansion strategies. AMO can also capitalize on the healthcare firm’s strong reputation and global presence in international markets. So could this $2.8 billion deal spell the first in a long line of acquisitions for 2009? I think so!

Change has also been the theme for Ophthalmology Times Europe as we kick off 2009. Okay, so maybe the scale of our changes cannot quite match those of the AMO acquisition but you may have noticed that the look, size and style of this issue of your magazine have changed, we hope, to better suit your needs. Please do feel free to contact us if you would like to make any suggestions or comments.

I would now like to take this opportunity to wish you all a very happy New Year. May 2009 bring you good health, success, and continued enjoyment from your monthly edition of Ophthalmology Times Europe!

Fedra Pavloufpavlou@advanstar.com

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.